Cooper, RachelKowalczuk, AleksandraWilkie, GwenVickers, MarkTurner, MarcCampbell, JohnFraser, Alasdair2021-10-122021-10-122021-10-31Cooper, R, Kowalczuk, A, Wilkie, G, Vickers, M, Turner, M, Campbell, J & Fraser, A 2021, 'Cytometric analysis of T cell phenotype using cytokine profiling for improved manufacturing of an EBV-specific T cell therapy', Clinical and Experimental Immunology, vol. 206, no. 1, 68-81. https://doi.org/10.22541/au.161002473.32537816/v1, https://doi.org/10.1111/cei.136400009-9104PubMedCentral: PMC8446406ORCID: /0000-0002-3154-1040/work/101394684https://hdl.handle.net/2164/17349Acknowledgements We gratefully acknowledge the voluntary donations of peripheral blood and leukapheresis samples used in this study. This study was supported by the staff of the Scottish National Blood Transfusion Service (SNBTS) Clinical Apheresis Unit, Aberdeen and medical colleagues at the New Zealand Blood Transfusion Service for collection of the donor leukapheresis material for the second iteration of the EBV-T cell bank. This work was supported by a Wellcome Trust Translational Award. The ongoing operation of the UK EBV-specific T cell bank is supported by cost-recovery fees and supported by SNBTS. Contributions RSC and AK were responsible for the acquisition and analysis of data, and RSC wrote the principal manuscript; GW and MV were involved in supply of material and interpretation of data; MLT, JDMC and ARF were responsible for study conception and design, data analysis and interpretation, and revision of the final manuscript.141354138engSDG 3 - Good Health and Well-beingcancercell differentiationcytotoxic T-cellsT-cellsviralR MedicineRJournal article10.22541/au.161002473.32537816/v12061